Birgitta Versluijs

128 Supplemental data TABLE S2. Predictor analyses for BOS. Univariate analyses (N = 9) HR (95% CI) P value Age at HCT 1.0 (0.9-1.1) .74 Sex  Male  Female 1 1.9 (0.9-3.8) .08 * HCT indication  Malignancy  Bone marrow failure syndrome  Inborn error of metabolism  Primary immune deficiency 1 0.0 (0-0) 0.8 (0.1-7.1) 2.5 (0.6-9.8) .99 .83 .20 Conditioning  Chemotherapy-based  TBI-based 1 0.0 (0.0-62.2) .38 Donor  MSD  MUD  uCB 1 0.7 (0.1-3.8) 0.4 (0.1-1.7) .67 .21 HLA matching  MSD 10/10 MUD  9/10 MUD  6/6 uCB  4-5/6 uCB 1 3.5 (0.4-30.4) 0.3 (0.0-2.9) 0.7 (0.1-3.4) .25 .32 .62 CMV serology recipient  Negative  Positive 1 4.3 (0.5-35.4) .18 NPA  RV negative  RV positive 1 5.7 (0.7-44.5) .10 BAL  RV negative  RV positive 1 5.3 (1.1-25.7) .04 * Abbreviations: CMV, Cytomegalovirus; MSD, matched sibling donor; MUD, matched unre- lated donor; TBI, total-body irradiation; uCB, unrelated cord blood. * Statistically significant 7